NAD+: What Researchers Have Actually Studied
- What it is: A coenzyme (nicotinamide adenine dinucleotide) found in every living cell, central to how cells turn fuel into energy.
- Researchers have studied it for: How NAD+ drops with age, its role as fuel for energy enzymes and sirtuins, and whether precursors can raise NAD+ in blood and brain.
- Evidence level: Mostly cell and animal work, plus small, early-phase human trials.
- The short version: Researchers measured NAD+ falling with age and tested whether oral precursors could push blood and brain levels back up. Most of the mechanism work is in cells and animals, and the human trials are small and early. Raising a marker is not the same as changing how a person feels or ages, and that link is not established.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell, and it sits at the center of how cells turn fuel into energy. This page walks through what researchers have looked at in the lab, in plain language, with links to the real studies.
Compound facts: NAD+ / beta-NAD+. CAS 53-84-9. Molecular weight 663.4 g/mol. Class: coenzyme (dinucleotide).
What researchers have studied
These are findings from published research. They describe what scientists measured in cells, in animals, and in early human studies. They are not claims about what any product does for a person.
NAD+ decline in aging and low-oxygen models. A 2019 review in *Biogerontology* describes NAD+ as a coenzyme that drops during aging and during ischemic (low blood flow) conditions. Researchers studied whether restoring NAD+ changed how cells function in those models. (PMID 30838484)
NAD+ as fuel for energy enzymes. A 2017 review in the *Journal of the Endocrine Society* lays out how NAD+ works as a coenzyme in the reactions that make cellular energy, and as a required substrate for sirtuins. Sirtuins are enzymes that adjust metabolism based on the cell’s energy status. (PMID 29264533)
NAD+ markers fall with age in human blood. A 2019 study in *Rejuvenation Research* measured NAD+ related molecules in people from age 20 to 87. It found that NAD+ and NADP+ dropped with age while other related forms rose. This is a biomarker study, not an outcome study. (PMID 30124109)
Raising blood NAD+ with an oral precursor. A 2019 randomized trial in *Scientific Reports* gave healthy adults different oral doses of nicotinamide riboside (an NAD+ precursor) for 8 weeks and measured how blood NAD+ metabolites changed by dose. Higher doses raised blood NAD+ markers in a dose-dependent way. (PMID 31278280)
Raising NAD+ in the brain in an early-phase trial. The NADPARK study, a 2022 randomized phase I trial in *Cell Metabolism*, gave nicotinamide riboside to newly diagnosed Parkinson’s patients and measured whether brain NAD+ levels rose. It is an early, small study focused on whether NAD+ can be raised, not on treating disease. (PMID 35235774, ClinicalTrials.gov NCT03816020)
How it works
NAD+ is an electron carrier. In plain terms, it picks up and drops off electrons during the reactions that turn food into ATP, the molecule cells use for energy.
It flips back and forth between two forms, NAD+ and NADH, during glycolysis, the citric acid cycle, and oxidative phosphorylation. That cycling is the link between the fuel a cell takes in and the energy it produces.
NAD+ is also used up by a group of enzymes, including sirtuins, PARPs, and CD38. Because those enzymes consume it, cells have to keep making more. Research has connected lower NAD+ levels to aging in several tissues, including muscle, liver, and brain.
What the research does not establish
This is the honest part. The findings above have real limits.
Most of the mechanism work is in cells and animals, not people. What happens in a dish or a mouse does not always carry over to a human.
Human trials so far are small and short. Several are early-phase. Raising a blood or tissue marker is not the same as changing how a person feels, performs, or ages. That link is not established.
No study here shows that NAD+ treats, prevents, or cures any condition. Etched Research makes no health claim. These are research findings in research models, and that is all they are.
Buyer-intent tag: NAD+ = Longevity / Energy (research-interest category, not a benefit claim)
For Research Use Only. Not for human consumption. Etched Research supplies compounds for laboratory and research use only. Independent identity and purity testing by Janoshik. Nothing on this page is medical advice, a health claim, or a recommendation to use.
Research-grade material, batch COA included. For research use only.